Register entry
Towa Pharmaceutical Europe, S.L.
- Registered sites
- 1
- Drug products
- 6
- Live patents
- 0
- Countries
- 1
- Base
- Spain
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingFinished drug manufacture
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Towa Pharmaceutical Europe, S.L. | MartorellesSpain | Analytical testing, Finished drug manufacture | 3003121577 |
Catalogue
Marketed products
6Showing 6 of 6.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | DULOXETINE HYDROCHLORIDE | CAPSULE, DELAYED RELEASE PELLETS | DRUG FOR FURTHER PROCESSING |
| - | DULOXETINE HYDROCHLORIDE | CAPSULE, DELAYED RELEASE PELLETS | DRUG FOR FURTHER PROCESSING |
| - | DULOXETINE HYDROCHLORIDE | CAPSULE, DELAYED RELEASE PELLETS | DRUG FOR FURTHER PROCESSING |
| - | DULOXETINE HYDROCHLORIDE | CAPSULE, DELAYED RELEASE PELLETS | DRUG FOR FURTHER PROCESSING |
| - | OMEPRAZOLE | CAPSULE, DELAYED RELEASE PELLETS | DRUG FOR FURTHER PROCESSING |
| - | OMEPRAZOLE | CAPSULE, DELAYED RELEASE PELLETS | DRUG FOR FURTHER PROCESSING |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.